Other members of ABC transporters including ABCB1 and ABCC1 are targeted to resolve MDR in cancer; however, it is important to mention that none of these drugs is pharmacologically successful with some causing adverse side effects on the function of normal cells [27]. The gene discussed is ABCG2; the disease is cancer.